Discover our range of Elite hybridoma cell lines and their validated antibodies

Highly validated antibodies focussed on fertility and hormonal control. Other end-utilities include Down’s diagnosis, pre-eclampsia, chronic fatigue syndrome, oncology, therapeutics for polycystic ovaries and other research fields.

 

Our 25 Elite Antibodies target a wide variety of research areas and are confirmed for use in applications including Western Blot, ELISA, Immunohistochemistry and Immunofluorescence

Highly validated with
over 150 citations

Datasheets available for
all cell lines

Hybridoma cell lines licensed for research and commercial use

Cat No. & CloneTargetApplicationsDatasheets

PPG5/10

Estrogen Receptor ß1WB, IHC, IF

57/3

Estrogen Receptor ß2WB, IHC, IF

PPG5/25

Estrogen Receptor ß5WB, IHC, IF

17/2a

Follistatin (FS288)ELISA, WB, IHC, ICC

H10

Follistatin (raised to FS315)ELISA, WB, IHC

29/9a

Follistatin (FS288)ELISA

BetaC1

Activin CWB, IHC

H4

CYP450 AromataseWB, IHC, IF, ICC

MBP2

Myelin Basic Protein (region 119-131)ELISA, WB, IHC, IF, IP

MBP1

Myelin Basic Protein (region 129-138)ELISA, WB, IHC, ICC

MBP12b

Myelin Basic Protein (region 82-87)ELISA, WB, IHC, IF, ICC

MBP14

Myelin Basic Protein (region 36-50)ELISA, WB, IHC, IF, ICC

MBP40b

Myelin Basic ProteinELISA

98/P12

Myelin Basic Protein (Thr98)ELISA, WB, ICC

3/11A

Deleted in azoospermia-like (DAZL)WB, IHC, IF

133

Protein Kinase C αWB, IHC

PO12/8

Inhibin αELISA, IHC

PO23/32

Inhibin αELISA

PLPC1

Proteolipid ProteinWB, IHC, IF, ICC

28A

Growth Differentiation Factor 9BELISA, WB, ICC, IB

53/1

Growth Differentiation Factor 9ELISA, WB, IHC

72B

Growth Differentiation Factor 9ELISA, WB

32F8c

AdiponectinELISA

399Rc

AdiponectinELISA

Myo2/1A

MyostatinWB, ICC

Sandwich ELISAs
a – 29/9 is used as the capture, 17/2 as the detection
b – MBP clones 12 and 40 are used interchangeably
c – 399R is used as the capture, 32F8 as detection

To enquire about our range of ELITE antibodies, don’t hesitate to email us at info@bioservuk.com

Back to Top